Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE)

Blauvelt, Andrew; C. Prinz, Jörg; B. Gottlieb, Alice; Kingo, Külli; Sofen, Howard; Ruer‐Mulard, M.; K. SINGH, Vijendra; Pathan, R.; Papavassilis, C.; Cooper, Simon; FEATURE Study Group, the

doi:10.1111/bjd.13348

Public

Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE)

Published in British Journal of Dermatology • Aug 16, 2014

Authors:

Andrew Blauvelt

Jörg C. Prinz

Alice B. Gottlieb

Abstract

BACKGROUND: Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-to-severe plaque psoriasis when administered via subcutaneous injection. Self-administration by pre-filled syringe (PFS) can offer patients clinical benefits of a drug, with ...

Subject

Secukinumab

Medicine

Psoriasis

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!